Tag Archives: Primary

COVID-19 survey shows 85% of primary care practices lack personal protection equipment and tests

A new survey has found that 46% of primary care physician practices have no capacity for COVID-19 testing and 51% lack adequate personal protective equipment. More than half, 52% of practices, report COVID-19 is having severe and near severe impact on their practice. Fifty-eight percent have cancelled well and chronic care visits to accommodate need… Read More »

I Have a Strong Relationship with my Bank but I Almost Never Go There. How Could this Translate to Primary Care?

By HANS DUVEFELT, MD Imagine if your bank handled all your online transactions for free but charged you only when you visited your local branch – and then kept pestering you to come in, pay money and chat with them every three months or at least once a year if you wanted to keep your… Read More »

How tech-infused primary care centers turned One Medical into a $2 billion business

Amir Rubin, new CEO of One Medical One Medical Two years after leaving the traditional health-care world to lead primary care upstart One Medical, Amir Dan Rubin now faces a clear challenge. With competition heating up, he needs to rapidly expand the business into new areas without sacrificing the luxe service that patients have come… Read More »

MedPAC urges MA data, primary care reforms

Dive Brief: In its annual report to Congress, the Medicare Payment Advisory Committee issued three recommendations impacting Medicare Advantage plans, ER spending and primary care. The commissioners recommended Congress allow advanced practice registered nurses and physician assistants to bill Medicare directly, to shed light on current treatment and help ease primary care access issues. Concerned… Read More »

FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis

FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis Print this page November 20, 2018 — The U.S. Food and Drug Administration today approved Gamifant (emapalumab) for the treatment of pediatric (newborn and above) and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) who have refractory, recurrent or progressive disease or intolerance with conventional HLH therapy. This… Read More »